Clinical Trial Update: Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating a double-dose primaquine regimen for radical cure of Plasmodium vivax in Colombia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria
• Malaria Vivax

Drugs mentioned

• Primaquine (primaquine)

Snippet

Sponsor: University of California, San Francisco | Conditions: Malaria, Vivax, Relapse | Phase 2, Phase 3 | Status: WITHDRAWN